US20020198572A1 - Peripheral nerve stimulation apparatus - Google Patents

Peripheral nerve stimulation apparatus Download PDF

Info

Publication number
US20020198572A1
US20020198572A1 US10208146 US20814602A US2002198572A1 US 20020198572 A1 US20020198572 A1 US 20020198572A1 US 10208146 US10208146 US 10208146 US 20814602 A US20814602 A US 20814602A US 2002198572 A1 US2002198572 A1 US 2002198572A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
neuralgia
emanating
nerve
peripheral nerve
apparatus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10208146
Inventor
Richard Weiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551Spinal or peripheral nerve electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0504Subcutaneous electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526Head electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36071Pain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/40Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals

Abstract

A method for treating pain by subcutaneous electrical stimulation of a peripheral nerve is disclosed. A lead is placed subcutaneously over a peripheral nerve that is causing pain. The peripheral nerve is electrically stimulated to cause paresthesia. The method encompasses subcutaneous placement of an electrical lead near any peripheral nerve causing pain and subsequent electrical stimulation of the nerve to cause paresthesia. In particular, a method for treating intractable occipital neuralgia using percutaneous peripheral nerve electrostimulation techniques is disclosed.

Description

  • This patent application is a continuation of U.S. patent application Ser. No. 09/577,258, filed May 22, 2000, for which priority is claimed. This parent application is incorporated herein by reference in its entirety.[0001]
  • FIELD OF THE INVENTION
  • This invention relates to a method for subcutaneously electrically stimulating peripheral nerves and in a particular embodiment relates to a method for subcutaneously electrically stimulating one or more occipital peripheral nerve to treat occipital neuralgia. [0002]
  • DESCRIPTION OF RELATED ART
  • Peripheral nerves are nerves in the body other than the nerves of the brain or spinal cord. Peripheral nerve injury may result in the development of chronic intractable pain. Some patients prove unresponsive to conservative pain management techniques. Peripheral Nerve Stimulation (PNS) has developed as a successful therapy for pain management when the pain is known to result from a specific nerve. PNS is based in part on the Melzack-Wall gate control theory of pain. Sweet and Wespic first used electrical stimulation of peripheral nerves in the 1960s to mask the sensation of pain with a tingling sensation (paresthesia) caused by the electrical stimulation. Subsequent refinements in the technology, surgical technique and patient selection have led to improved long term results. [0003]
  • PNS is an accepted alternative for those patients who have failed more conservative pain management therapies. Clinical experience has shown that when applied to appropriate patients by trained practitioners, PNS can reduce pain, reduce narcotic intake to manage pain and improve the patient's activity levels and their quality of life. PNS has been recognized to have the following desirable characteristics: [0004]
  • The surgical procedure is relatively simple. [0005]
  • PNS is nondestructive. No known permanent surgical or chemical interruption of nerve pathways occurs. [0006]
  • PNS is reversible. If the patient does not benefit, the device can be turned off or removed. There are no known long-lasting medical or surgical side effects. [0007]
  • Patients can be tested for response prior to implant of the complete system. [0008]
  • Occipital nerves [0009] 2, 4 and 6 (FIG. 1) are peripheral nerves that exit the spinal cord at the C2 level of the cervical vertebrae and extend upward generally along the back and back-sides of the head. The lesser occipital nerve 2 extends upward and toward the sides of the head. The greater occipital nerve 4 extends upward toward the top of the head. The third occipital nerve 6 extends from near the neck around the back of the head toward the ear. Because of the location where the occipital nerves leave the spinal cord, the occipital nerves pass from the spinal column through muscle and fascia to the scalp.
  • Occipital neuralgia is a condition characterized by paroxysms of pain occurring within the distribution of the greater and/or lesser occipital nerves. Occipital neuralgia has been described as a “jabbing” pain in the area of the greater or lesser occipital nerve. The pain may radiate from the back or sides of the head toward the top or front of the head. Patients will vary in their reporting of this pain. It has been characterized in the medical literature as a unilateral or bilateral throbbing pain that frequently radiates to the forehead and to the frontal region (Stechison and Mullin, 1992) or as a lancinating pain extending from the suboccipital region up to the top of the head. The pain is less often described as including or consisting of a dull aching” (Sulfaro and Gobetti, 1995). Occipital neuralgia is often accompanied by diminished sensation and sometimes extreme localized tenderness over the applicable nerve. [0010]
  • Though known causes of occipital neuralgia include closed head injury, direct occipital nerve trauma, neuroma formation or upper cervical root compression (spondylosis or ligamentous hypertrophy), most patients have no demonstrable lesion. An anesthetic block of the greater occipital nerve can be used to confirm the diagnosis of occipital neuralgia (Khun, et al., 1997). [0011]
  • Traditional treatment options for intractable occipital nerve pain that has proven to be resistant to medications usually involve chemical, thermal or surgical ablation procedures following diagnostic local anesthetic blockade. Surgical approaches include neurolysis or nerve sectioning of either the occipital nerve in the occipital scalp or at the upper cervical dorsal root exit zone (extradural). Forammal decompression of C2 roots as well as C2 ganglionectomy have also been effective in reported cases. [0012]
  • Many patients with occipital neuralgia do not favorably respond to these medical treatments. Therefore, there is a need for an additional effective treatment of occipital neuralgia. [0013]
  • BRIEF SUMMARY OF THE INVENTION
  • A method for treating pain by subcutaneous electrical stimulation is disclosed. A lead is placed subcutaneously over (superior to) a peripheral nerve that is causing pain. The nerve is electrically stimulated to cause paresthesia. As a result, the pain is masked. The method of the invention encompasses subcutaneous placement of an electrical lead near any peripheral nerve causing pain and subsequent electrical stimulation of the nerve to cause paresthesia. [0014]
  • In particular, a method for treating intractable occipital neuralgia using percutaneous peripheral nerve electrostimulation techniques is disclosed. The method involves a subcutaneous electrode placement at the level of C1 transversely across the base of the occipital nerve trunk and subsequent electrical stimulation of the occipital nerve trunk. This stimulation produces paresthesia and pain relief covering the regions of occipital nerve pain. [0015]
  • It is therefore an object of the invention to provide a method for subcutaneously electrically stimulating nerves causing pain to create paresthesia. [0016]
  • It is another object of the invention to provide a method for percutaneously placing leads subcutaneously to create paresthesia. [0017]
  • These and other object of the invention will be clear from the following detailed description of the invention.[0018]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a schematic view of the occipital nerves. [0019]
  • FIG. 2 is a schematic view of the hardware used to practice the invention of the present invention. [0020]
  • FIG. 3 is a perspective view of a screener device and a screening lead. [0021]
  • FIG. 4 is a top view of a permanent lead. [0022]
  • FIG. 5 is a perspective view of an implantable pulse generator (IPG). [0023]
  • FIG. 6 is a perspective view of an RF system receiver and an RF system transmitter. [0024]
  • FIG. 7 is a top view of an introducer needle curved to facilitate placement of the permanent lead to treat occipital neuralgia. [0025]
  • FIG. 8 is a schematic view of the entry site used to implant a screening lead or a permanent lead for treating occipital neuralgia. [0026]
  • FIG. 9 is a schematic view of the placement of the introducer needle prior to placing the screening lead. [0027]
  • FIG. 10 is a schematic view of the placement of the introducer needle with the screening lead being inserted into the introducer needle. [0028]
  • FIG. 11 is a schematic view of dual leads placed to treat bi-lateral pain. [0029]
  • FIG. 12 is a perspective view of a patient prior to being implanted with a permanent lead. [0030]
  • FIG. 13 is a schematic view of the placement of the introducer needle prior to placing the permanent lead. [0031]
  • FIG. 14 is a schematic view of the placement of the introducer needle with the permanent lead being inserted into the introducer needle. [0032]
  • FIG. 15 is a schematic view of the location of the subcutaneous pocket for housing the loop of the permanent lead and the lead anchor. [0033]
  • FIG. 16 is a perspective view of a human torso and arm showing the location of the leads for two embodiments of the invention. [0034]
  • FIG. 17 is a perspective view of a human torso and arm showing the exit sites of the leads and preferred location for an IPG for the method of FIG. 16. [0035]
  • FIG. 18 is a perspective view of a human leg showing the location of a lead and IPG for an embodiment of the invention. [0036]
  • FIG. 19 is a perspective view of a human leg showing the location of a lead and IPG for another embodiment of the invention.[0037]
  • DETAILED DESCRIPTION OF THE INVENTION
  • The present invention comprises a method of stimulating peripheral nerves. The method is preferentially accomplished in two stages: a test implantation and screening stage and a permanent implantation of a lead and electrical stimulation system stage. The invention contemplates using, as shown in FIG. 2, a screening lead [0038] 10 (shown in detail in FIG. 3), a screener device 12 (also shown in detail in FIG. 3), a permanent lead 14 (shown in detail in FIG. 4) and either an implanted pulse generator (IPG) 16 (shown in detail in FIG. 5) or an implanted RF system receiver 18 and its corresponding RF system transmitter 20 (shown in detail in FIG. 6).
  • The screening lead [0039] 10 and permanent lead 14 are preferably percutaneous leads chosen from the Pisces-Quad® family of quadripolar leads. Screener device 12 is preferably a Model 3625 Screener or a Model 3628 DualScreen® Screener. IPG 16 is preferably an Itrel® IPG. RF system receiver 18 and RF system transmitter 20 are both preferably part of an RF stimulation system such as the X-trell® or Matrix® RF Stimulation Systems. Screening lead 10, permanent lead 14, screener device 12, IPG 16, RF system receiver 18 and RF transmitter 20 are all available from Medtronic, Inc. of Minneapolis, Minn.
  • The method for treating pain due to peripheral nerves involves subcutaneous placement of a permanent lead [0040] 14 transversely across the peripheral nerve that is causing the pain. This peripheral nerve is subsequently electrically stimulated to cause paresthesia of the painful area. The method also preferably involves placement of a screening lead 10 and subsequent test electrical stimulation prior to placing the permanent lead 14. Although the method preferably involves placing both a screening lead 10 and then a permanent lead 14, the method also includes implanting just the permanent lead 14 as will be described in detail hereafter. For illustration purposes, the method for treating pain due to peripheral nerves will be described with reference to treating occipital neuralgia by electrically stimulating the occipital nerves.
  • One key to the technical success of this invention is the accurate placement of the permanent lead [0041] 14. Because of the importance of accurate placement of the permanent lead 14, accurate placement of permanent lead 14 is facilitated by the placement of the screening lead 10 and the subsequent test electrical stimulation. The steps in the invention to percutaneously place a screening lead 10 to treat occipital neuralgia will now be described in detail. These steps are given as the preferred method of implementing the invention for most patients. It is recognized, however, that the skilled physician will adapt the method described herein using his or her professional skill and judgment to the particular circumstances of a particular patient. Further, although the method of treating pain described in detail herein is specifically directed to treating occipital neuralgia, unless otherwise specifically directed, any reference to the occipital nerve or occipital neuralgia refers as well to any peripheral nerve or neuralgias corresponding to a peripheral nerve, respectively.
  • The first step of the test implantation and screening stage is the implantation of a screening lead [0042] 10. The method involves subcutaneous placement of a screening lead 10 in the fascia 34 above (superior to) the occipital nerve causing pain and proximal to the level of detected pain. The first step in locating the area to implant the screening lead 10 is to palpate the area of pain to identify the specific nerve that is causing the pain. If it is confirmed that an occipital nerve is causing the pain and the specific occipital nerve has been identified, an introducer needle 22 is used to place the screening lead 10.
  • The preferred embodiment for the introducer needle [0043] 22 is a Touhy needle. As shown in FIG. 7, the introducer needle 22 has a terminal end 24 that has a beveled edge 26 and a proximal end 28 that includes a hub 30. Beveled edge 26 is a sharp edge that allows the terminal end 24 to be pushed through tissue. Hub 30 allows the physician to manipulate the introducer needle 22. Hub 30 also has a notch 32 that is aligned with the beveled edge 26 to indicate the orientation of beveled edge 26 to the hub 30 by tactile sensation.
  • The introducer needle [0044] 22 is then subcutaneously placed in the fascia 34 above (superior to) the nerve 36 that is causing the pain. In the case of treating occipital neuralgia, the introducer needle 22 is placed in the fascia 34 above (superior to) the occipital nerve that is causing the pain. Fascia 34 is a sheet of fibrous tissue that envelops the body under the skin and also encloses the muscles. In the described method, the introducer needle 22 will be introduced into the fascia 34 so that the introducer needle will be between the patient's skin and muscle. The nerve causing the pain will be located within or under the musculature. In the case of treating occipital neuralgia, the introducer needle 22 will be introduced into the fascia 34 so that the introducer needle will be between the patient's skin and the occipital nerve.
  • The introducer needle [0045] 22 is preferably introduced through a small stab wound “A” at the needle entry site (FIG. 8). Rapid needle insertion is preferably used. This technique usually obviates the need for even a short acting general anesthetic.
  • The introducer needle [0046] 22 is moved through the fascia 34 to a position over the occipital nerve that is causing the pain (FIG. 9). When the introducer needle 22 is in position above the occipital nerve, the screening lead 10 is passed through the introducer needle 22 (FIG. 10) until the screening lead 10 is also in position above the occipital nerve causing the pain. Then, the introducer needle 22 is removed leaving the screening lead 10 in place above the occipital nerve.
  • Single or dual quadripolar as well as single or dual octapolar screening leads [0047] 10 may be used depending on whether the pain is unilateral (on one side of the body only) or bilateral (on both sides of the body). Where the pain is bilateral and two screening leads 10 are used (FIG. 11), each screening lead 10 will be placed as described above.
  • Following placement of the screening lead [0048] 10 by the introducer needle 22, the screening lead 10 is connected to the screening device 12, as is well understood in the art. With the screening lead 10 in place as described above and the screening lead 10 connected to the screening device 12, the patient is electrically stimulated by the screening lead 10 and screener device 12 to evaluate the screening lead 10 position and to develop optimal stimulation parameters. Stimulation is applied using the screener device 12 to select various electrode combinations, enabling the patient to report stimulation location, intensity and overall sensation. This allows the physician to test the stimulation and determine optimum stimulation parameters prior to permanently implanting the permanent lead 14 and the source of electrical stimulation pulses, either the IPG 16 or the RF system receiver 18. The effect of this stimulation is determined and the parameters of stimulation adjusted for optimal pain relief. It is preferred that the patient be awake and alert so that the patient will provide verbal feedback regarding paresthesia coverage of the painful area to assist in determining the optimum stimulation parameter settings.
  • The following have been found to be typical ranges for stimulation parameters for screening by the screener device [0049] 12 and the screening lead 10 to optimize paresthesia levels for pain coverage. These parameters can vary from patient to patient and may be outside the ranges given here. Never-the-less, these representative values are given for the purpose of illustrating the invention and not for the purpose of limiting the invention. Values for these parameters may be higher or lower than the values shown.
    Amplitude: 0.5-4.0 volts
    Pulse Width:  90-200 μsec
    Rate:  50-400 Hz
  • If the patient reports muscle contractions (grabbing sensation) or burning, this usually indicates that the screening lead [0050] 10 is located too deep (anterior) in the subcutaneous tissue. It may also indicate that the screening lead 10 is not positioned correctly above (superior to) the nerve. It may be necessary to remove and reposition the screening lead 10. If adjustment of screening lead 10 is necessary, the screener device 12 is removed from the screening lead 10. Then, the position of the screening lead 10 is adjusted and stimulation is tested again for optimal pain relief. Adjusting the position of the screening lead 10 may mean removing the screening lead 10 and re-implanting the screening lead 10 according to the technique described above.
  • After good paresthesia coverage is obtained by manipulating the parameters of stimulation applied through screening lead [0051] 10, percutaneous testing wires can be externalized for the test stimulation period as is well understood in the art. This period is used to evaluate the patient's response to stimulation before complete implantation of all system components.
  • Alternately, once satisfactory paresthesia is confirmed, the screener device [0052] 12 may be removed from the screening lead 10 and a source of electrical stimulation pulses such as the IPG 16 or RF system receiver 18 is immediately implanted and attached to the screening lead 10. Hence, screening lead 10 in this embodiment becomes permanent lead 14. However, it is preferred that the patient use the implanted screening lead 10 and screener system 12 for several days prior to implanting a permanent stimulation system.
  • Once the screening lead [0053] 10 has been appropriately positioned and tested, if satisfactory results are obtained, the method should proceed to the “permanent implantation of a lead and electrical stimulation system” stage. The steps in the invention to permanently implant a stimulation system will now be described in detail in connection with the treatment of occipital neuralgia. As mentioned above, it is possible to implant a source of electrical stimulation pulses such as the IPG 16 or RF system receiver 18 and attached it directly to the screening lead 10 so that screening lead 10 becomes the permanent lead 14. However, the preferred embodiment of the invention contemplates removing the screening lead 10 and replacing it with a permanent lead 14.
  • After it has been determined that the patient is receptive to pain relief from electrically stimulating the peripheral nerve causing the pain and the paresthesia associated with the electrical stimulation has been maximized, the screener device [0054] 12 is disconnected from the stimulation lead 10 and the screening lead 10 is removed. The patient is then prepared for placement of the permanent lead 14 and the implanted pulse generator (IPG) 16 or implanted RF system receiver 18. The purpose of the “permanent implantation of a lead and electrical stimulation system” stage is to internalize (that is, implant) the permanent lead 14 and either the IPG 16 or the RF system receiver 18. Therefore, this stage includes implanting the permanent lead 14, neurostimulator (either IPG 16 or RF system receiver 18) and any extension sometimes used to connect permanent lead 14 and either IPG 16 or RF system receiver 18 as is well understood in the art.
  • As stated above, one key to the technical success of this invention is the accurate placement of the permanent lead [0055] 14. It is therefore crucial to the success of the invention to have a lead placement for the permanent lead 14 that results in paresthesia that covers the patient's painful area. Therefore, lead placement is preferably determined using patient feedback during intraoperative testing of the efficacy of the permanent lead 14 placement and the stimulation parameters. Performing implantation of the permanent lead 14 under local anesthetic allows for this feedback.
  • A local anesthetic is preferably used in the area of the introducer needle [0056] 22 entry site to ensure the patient is alert and able to respond during the procedure. To help the patient relax, sedatives are also preferably administered intravenously. Prophylactic antibiotics can also be administered intravenously for protection from postoperative infection. As a result, the patient is preferably awake and alert during the placement of the permanent lead 14 and the subsequent test stimulation.
  • Where treating occipital neuralgia, the patient is preferably placed in a lateral position, or in a prone position with the head to the side, on a radiolucent table (FIG. 12). The patient is prepared and draped according to standard surgical procedure. Fluoroscopy is used to identify the location of the C1 vertebra. The location and midline of the C1 vertebra is marked on the patient's skin with a sterile marker. [0057]
  • A Touhy needle is preferably used as an introducer needle [0058] 22 to introduce permanent lead 14. The introducer needle 22 includes a stylet 42. The introducer needle 22 is manually gently curved by the physician to conform to the contour of the patient's body above the peripheral nerve to facilitate placement of the permanent lead 14. Where the peripheral nerve is the occipital nerve, the introducer needle 22 is manually gently curved by the physician to conform to the contour of the patient's neck (FIG. 7) to facilitate placement of the permanent lead 14.
  • A small stab wound “A” is made at the needle entry site (FIG. 8) at the C1 level. Using local anesthesia, a 2 cm. vertical skin incision is made in the patient's neck lateral to the midline of the spine at the level of C1. The introducer needle [0059] 22 is introduced into the subcutaneous tissue, superficial to the fascia 34 and muscle layer but below the skin, without further dissection across the trunk of the occipital nerves. These nerves are located within the cervical musculature and overlying fascia 34.
  • The physician then advances the introducer needle [0060] 22 transversely from the lateral incision point to and across the midline of the spine under fluoroscopic observation to the appropriate location above the trunk of the occipital nerve (FIG. 13). The beveled edge 26 of the introducer needle 22 should face toward the front of the body (anterior). The orientation of the beveled edge 26 can be verified by referring to the notch 32 on the needle hub 30 of the introducer needle 22.
  • The curve of the introducer needle [0061] 22 may be checked, if desired, by the physician by removing and re-inserting the needle stylet 42. A useful, curved introducer needle 22 is ensured if it is easy to remove and reinsert the stylet 42 within the introducer needle 22. If desired, an additional check can be made by removing the stylet 42, then carefully inserting the permanent lead 14 through the introducer needle 22 to just beyond the beveled edge 26 of the introducer needle 22. If the curvature of the introducer needle 22 is correct, the permanent lead 14 should pass easily to just beyond the beveled edge 26 of the introducer needle 22. The permanent lead 14 is then removed and the stylet 42 re-inserted into the introducer needle 22.
  • Once the desired position has been reached, the stylet [0062] 42 is removed from the introducer needle 22. The permanent lead 14 is slowly inserted through the introducer needle 22 until the distal tip 36 of the permanent lead 14 just exits the introducer needle 22 (FIG. 14). Then, the introducer needle 22 is carefully removed over the permanent lead 14. The permanent lead 14's placement is verified with fluoroscopy. Alternately, the introducer needle 22 can be partially removed. This allows the electrode contacts on the permanent lead 14 to be exposed while facilitating introducer needle 22 reinsertion if repositioning of the permanent lead 14 is needed. Fluoroscopy is used to ensure that all electrodes of the permanent lead 14 are exposed. If necessary, the introducer needle 22 may be adjusted to move the permanent lead 14 to a location where the permanent lead 14 will optimally stimulate the targeted occipital nerve(s).
  • If more than one permanent lead [0063] 14 is to be implanted, for example, on each side of the midline to treat bilateral pain, the procedure described above is repeated for each such permanent lead 14.
  • Following placement of the permanent lead [0064] 14 by the introducer needle 22, the permanent lead 14 is again connected to the screening device 12, as is well understood in the art. This allows the physician to test the stimulation and confirm that paresthesia is obtained with the placement of the permanent lead 14 prior to permanently implanting the IPG 16 or the RF system receiver 18. Since the patient is preferably awake and alert, the patient will provide verbal feedback regarding paresthesia coverage of the painful area to assess the placement of the permanent lead 14.
  • If the patient reports muscle contractions (grabbing sensation) or burning, this usually indicates that the electrodes on the permanent lead [0065] 14 are too deep (anterior) in the subcutaneous tissue. It may also indicate that the electrodes are significantly above or below the C1 landmark. It may be necessary to remove and reposition the permanent lead 14. If adjustment of permanent lead 14 is necessary, the screener device 12 is removed from the permanent lead 14. Then, the position of the permanent lead 14 is adjusted and stimulation is tested again.
  • After good paresthesia coverage is obtained, the screener device [0066] 12 is removed from the permanent lead 14. It is now possible to implant the source of electrical stimulation pulses such as the IPG 16 or RF system receiver 18 and any extension sometimes used to connect permanent lead 14 and either IPG 16 or RF system receiver 18 as is well understood in the art. Internalization of the neurostimulation system for occipital nerve stimulation preferably follows the protocol used for other Peripheral Nerve Stimulation (PNS) indications as is well understood in the art. Basically, the procedure involves creating a subcutaneous pocket 24 in tissue (FIG. 15), anchoring the permanent lead 14, implanting the IPG 16 or RF system 18, tunneling the permanent lead 14 and connecting the permanent lead 14 to the IPG 16 or RF system 18 as is well understood in the art.
  • The following have been found to be typical ranges for stimulation parameters applied to the permanent lead [0067] 14 to obtain optimum paresthesia levels for pain coverage to treat occipital neuralgia. These values can vary from patient to patient and may be outside the ranges given here. Never-the-less, these representative values are given for the purpose of illustrating the invention and not for the purpose of limiting the invention. Again, values for these parameters may be higher or lower than the values shown.
    Amplitude: 0.5-4.0 volts
    Pulse Width:  90-200 μsec
    Rate:  50-400 Hz
  • These steps are given as the preferred method of implementing the invention for most patients. It is recognized, however, that the skilled physician will adapt the method described herein using his or her professional skill and judgment to the particular circumstances of a particular patient. [0068]
  • A specific example of percutaneous nerve stimulation has been given for treating occipital neuralgia. Although the method of treating occipital neuralgia has been described in detail, the steps described can be adapted to treating other peripheral nerve applications as medical judgment and necessity require. Examples of other applications for the described subcutaneous PNS technique include peripheral nerves in the head and neck, trunk and limbs. Examples of neuralgias in the head and neck that can be treated by stimulating peripheral nerves include, but are not limited to, post herpetic neuralgia, chronic deafferentation pain, chronic peripheral nerve pain, post craniotomy pain and incisional pain. For post herpetic neuralgia, the permanent lead [0069] 14 should preferably be placed in the vicinity of the supraorbital nerve in the forehead area. For chronic deafferentation pain, the permanent lead 14 should preferably be placed subcutaneously in the vicinity of the deafferentation pain. For chronic peripheral nerve pain, the permanent lead 14 should preferably be placed proximal to any peripheral nerve throughout the body. For chronic post craniotomy pain, the permanent lead 14 should preferably be placed in the region of the craniotomy incision.
  • Examples of neuralgias in the trunk that can be treated by stimulating peripheral nerves include, but are not limited to, clunial nerve pain, post herniorrhapy pain, localized low back or other spine pain and incisional neuroma pain. For clunial nerve pain, the permanent lead [0070] 14 should preferably be placed over the clunial nerve in the buttock area. For post herniorrhapy pain, the permanent lead 14 should preferably be placed subcutaneously in the region of the iliolinguinal nerve. For localized low back or other spine pain, the permanent lead 14 should preferably be placed in the vicinity of the localized area of pain. For incisional neuroma pain, the permanent lead 14 should preferably be subcutaneously placed in the region of the incisional neuroma.
  • Examples of neuralgias in the limbs that can be treated by stimulating peripheral nerves include, but are not limited to, stump neuroma pain, incisional scar pain, deafferention pain and chronic peripheral nerve pain as for example with the median nerve or ulnar nerve. For stump neuroma pain, the permanent lead [0071] 14 should preferably be subcutaneously placed in the region of the neuroma. For incisional scar pain, the permanent lead 14 should preferably be subcutaneously placed in the region of the incision. For chronic peripheral nerve pain of the medial nerve or ulnar nerve, the permanent lead 14 should preferably be placed over the medial nerve 38 or ulnar nerve 40, respectively, as shown in FIG. 16. Here, the technique described above is applied to the placement of screening lead 10 and permanent lead 14 with the leads 10, 14 located above (superior to) the desired peripheral nerve through medial nerve incision site 42 and ulnar nerve incision site 44, respectively. Once the permanent lead 14 is in place, the IPG 16 or RF system receiver 18 is implanted as is well understood in the art (FIG. 17) and connected to the permanent lead 14.
  • FIGS. [0072] 18 shows the placement of a permanent lead 14 next to the sciatic nerve 46 in the leg. Permanent lead 14 is implanted as described above through the sciatic nerve incision site 48. Placement of permanent lead 14 and the subsequent electrical stimulation of the sciatic nerve 46 could treat neuromas or chronic pain emanating from this peripheral nerve.
  • Further, FIG. 19 shows the placement of a permanent lead [0073] 14 next to a peripheral nerve 48 in the ankle, foot or other localized are of pain. Permanent lead 14 is implanted as described above through a peripheral nerve incision site 50. Placement of permanent lead 14 and the subsequent electrical stimulation of the affected peripheral nerve 44 could also treat neuromas in or around this peripheral nerve and also chronic pain arising from this nerve.
  • The examples of the method of the invention shown in FIGS. [0074] 16-19 have been given to illustrate examples of peripheral nerves to which the present method could apply. The application of the present invention to other peripheral nerves with their corresponding maladies and neuromas will occur to those skilled in the art. Conversely, once neurological maladies or neuromas and their corresponding peripheral nerves have been identified, as will also occur to those skilled in the art, the present invention may be used to treat such maladies or neuromas. It is clear that those skilled in the art will be able to practice the invention described above as applied to any peripheral nerve or to treat any particular neuroma by applying the disclosed method to its corresponding peripheral nerve.
  • The description contained herein is intended to be illustrative and not exhaustive. Many variations and alternatives will occur to one of ordinary skill in this art. All these alternatives and variations are intended to be included within the scope of the attached claims. Those familiar with the art may recognize other equivalents to the specific embodiments described herein which equivalents are also intended to be encompassed by the claims attached hereto. [0075]

Claims (34)

    What is claimed is:
  1. 1. An apparatus for treating neuralgia emanating from a peripheral nerve of a patient comprising in combination:
    (a) an implantable signal generator for providing electrical stimulation;
    (b) an implantable lead having a proximal end coupled to the signal generator and a stimulation portion adapted to be implanted in a fascia superior to and near the peripheral nerve to cause paresthesia of a neuralgia emanating area,
    whereby the implantable signal generator is capable of providing electrical stimulation to the peripheral nerve via the stimulation portion of the implantable lead to cause parasthesia of the neuralgia emanating area.
  2. 2. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 1, wherein the neuralgia is selected from the group consisting of post herpetic neuralgia, chronic deafferentation pain, chronic peripheral nerve pain, post crainiotomy pain, incisional pain, clunial pain, post herniorrhapy pain, localized low back or other spine pain, incisional neuroma pain, stump neuroma pain, incisional scar pain, deafferention pain, chronic peripheral nerve pain, sciatic neuralgia, medical neuralgia and ulnar neuralgia.
  3. 3. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 1, further comprising an introducer needle capable of being placed in the fascia superior to the peripheral nerve and capable of passing the implantable lead so that the stimulation portion is in position above the peripheral nerve.
  4. 4. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 3, wherein the introducer needle is curved so as to conform to a contour of the patient's body superior to the peripheral nerve.
  5. 5. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 1, wherein the implantable lead is a dual lead.
  6. 6. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 1, wherein the stimulation portion of the implantable lead is adapted to be implanted near a supraorbital nerve.
  7. 7. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 1, wherein the stimulation portion of the implantable lead is adapted to be implanted near a clunial nerve.
  8. 8. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 1, wherein the stimulation portion of the implantable lead is adapted to be implanted near a iliolinguinal nerve.
  9. 9. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 1, wherein the stimulation portion of the implantable lead is adapted to be implanted near a median nerve.
  10. 10. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 1, wherein the stimulation portion of the implantable lead is adapted to be implanted near an ulnar nerve.
  11. 11. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 1, wherein the stimulation portion of the implantable lead is adapted to be implanted near a sciatic nerve.
  12. 12. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 1, further comprising a screening device capable of being coupled to the implantable lead for performing test electrical stimulation with the implantable lead.
  13. 13. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 12, wherein the screening device is capable of delivering electrical stimulation having an amplitude between about 0.5 to about 4.0 volts.
  14. 14. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 12, wherein the screening device is capable of delivering electrical stimulation having a rate between about 50 Hz to about 400 Hz.
  15. 15. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 12, wherein the screening device is capable of delivering electrical stimulation having a pulse width between about 90 μsec to about 200 μsec.
  16. 16. An apparatus for treating neuralgia emanating from a peripheral nerve of a patient comprising in combination:
    (a) an RF system transmitter for generating RF signals;
    (b) an implantable RF system receiver for providing electrical stimulation in response to the RF signals;
    (c) an implantable lead having a proximal end coupled to the implantable RF system receiver and a stimulation portion adapted to be implanted in a fascia superior to and near the peripheral nerve to cause paresthesia of a neuralgia emanating area,
    whereby the implantable RF system receiver is capable of providing electrical stimulation to the peripheral nerve via the stimulation portion of the implantable lead to cause parasthesia of the neuralgia emanating area.
  17. 17. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 16, wherein the neuralgia is selected from the group consisting of post herpetic neuralgia, chronic deafferentation pain, chronic peripheral nerve pain, post crainiotomy pain, incisional pain, clunial pain, post herniorrhapy pain, localized low back or other spine pain, incisional neuroma pain, stump neuroma pain, incisional scar pain, deafferention pain, chronic peripheral nerve pain, sciatic neuralgia, medical neuralgia and ulnar neuralgia.
  18. 18. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 16, further comprising an introducer needle capable of being placed in the fascia superior to the peripheral nerve and capable of passing the implantable lead so that the stimulation portion is in position above the peripheral nerve.
  19. 19. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 18, wherein the introducer needle is curved so as to conform to a contour of the patient's body superior to the peripheral nerve.
  20. 20. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 16, wherein the implantable lead is a dual lead.
  21. 21. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 16, wherein the stimulation portion of the implantable lead is adapted to be implanted near a supraorbital nerve.
  22. 22. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 16, wherein the stimulation portion of the implantable lead is adapted to be implanted near a clunial nerve.
  23. 23. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 16, wherein the stimulation portion of the implantable lead is adapted to be implanted near a iliolinguinal nerve.
  24. 24. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 16, wherein the stimulation portion of the implantable lead is adapted to be implanted near a median nerve.
  25. 25. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 16, wherein the stimulation portion of the implantable lead is adapted to be implanted near an ulnar nerve.
  26. 26. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 16, wherein the stimulation portion of the implantable lead is adapted to be implanted near a sciatic nerve.
  27. 27. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 16, further comprising a screening device capable of being coupled to the implantable lead for performing test electrical stimulation with the implantable lead.
  28. 28. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 27, wherein the screening device is capable of delivering electrical stimulation having an amplitude between about 0.5 to about 4.0 volts.
  29. 29. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 27, wherein the screening device is capable of delivering electrical stimulation having a rate between about 50 Hz to about 400 Hz.
  30. 30. The apparatus for treating neuralgia emanating from a peripheral nerve of claim 27, wherein the screening device is capable of delivering electrical stimulation having a pulse width between about 90 μsec to about 200 μsec.
  31. 31. An apparatus for treating neuralgia emanating from an occipital nerve of a patient comprising in combination:
    (a) an implantable signal generator for providing electrical stimulation;
    (b) an implantable lead having a proximal end coupled to the signal generator and a stimulation portion adapted to be implanted in a fascia superior to and near the occipital nerve to cause paresthesia of a neuralgia emanating area,
    whereby the implantable signal generator is capable of providing electrical stimulation to the occipital nerve via the stimulation portion of the implantable lead to cause parasthesia of the neuralgia emanating area.
  32. 32. The apparatus for treating neuralgia emanating from an occipital nerve of claim 31, wherein the implantable lead is capable of being placed at a level of C1 transversely across a base of an occipital nerve trunk and wherein the implantable signal generator is capable of providing electrical stimulation to the occipital nerve trunk.
  33. 33. An apparatus for treating neuralgia emanating from an occipital nerve of a patient comprising in combination:
    (a) an RF system transmitter for generating RF signals;
    (b) an implantable RF system receiver for providing electrical stimulation in response to the RF signals;
    (c) an implantable lead having a proximal end coupled to the implantable RF system receiver and a stimulation portion adapted to be implanted in a fascia superior to and near the occipital nerve to cause paresthesia of a neuralgia emanating area,
    whereby the implantable RF system receiver is capable of providing electrical stimulation to the occipital nerve via the stimulation portion of the implantable lead to cause parasthesia of the neuralgia emanating area.
  34. 34. The apparatus for treating neuralgia emanating from an occipital nerve of claim 33, wherein the implantable lead is capable of being placed at a level of C1 transversely across a base of an occipital nerve trunk and wherein the implantable RF system receiver is capable of providing electrical stimulation to the occipital nerve trunk.
US10208146 1999-05-29 2002-07-30 Peripheral nerve stimulation apparatus Abandoned US20020198572A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US13669099 true 1999-05-29 1999-05-29
US09577258 US6505075B1 (en) 1999-05-29 2000-05-22 Peripheral nerve stimulation method
US10208146 US20020198572A1 (en) 1999-05-29 2002-07-30 Peripheral nerve stimulation apparatus

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10208146 US20020198572A1 (en) 1999-05-29 2002-07-30 Peripheral nerve stimulation apparatus
US11378094 US8774924B2 (en) 1999-05-29 2006-03-17 Peripheral nerve stimulation
US13272334 US9333339B2 (en) 1999-05-29 2011-10-13 Peripheral nerve stimulation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09577258 Continuation US6505075B1 (en) 1999-05-29 2000-05-22 Peripheral nerve stimulation method

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11378094 Continuation US8774924B2 (en) 1999-05-29 2006-03-17 Peripheral nerve stimulation

Publications (1)

Publication Number Publication Date
US20020198572A1 true true US20020198572A1 (en) 2002-12-26

Family

ID=26834551

Family Applications (4)

Application Number Title Priority Date Filing Date
US09577258 Active US6505075B1 (en) 1999-05-29 2000-05-22 Peripheral nerve stimulation method
US10208146 Abandoned US20020198572A1 (en) 1999-05-29 2002-07-30 Peripheral nerve stimulation apparatus
US11378094 Active 2023-09-30 US8774924B2 (en) 1999-05-29 2006-03-17 Peripheral nerve stimulation
US13272334 Active 2023-04-05 US9333339B2 (en) 1999-05-29 2011-10-13 Peripheral nerve stimulation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09577258 Active US6505075B1 (en) 1999-05-29 2000-05-22 Peripheral nerve stimulation method

Family Applications After (2)

Application Number Title Priority Date Filing Date
US11378094 Active 2023-09-30 US8774924B2 (en) 1999-05-29 2006-03-17 Peripheral nerve stimulation
US13272334 Active 2023-04-05 US9333339B2 (en) 1999-05-29 2011-10-13 Peripheral nerve stimulation

Country Status (1)

Country Link
US (4) US6505075B1 (en)

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050060008A1 (en) * 2003-09-15 2005-03-17 Goetz Steven M. Selection of neurostimulator parameter configurations using bayesian networks
US20050143787A1 (en) * 2002-05-09 2005-06-30 Boveja Birinder R. Method and system for providing electrical pulses for neuromodulation of vagus nerve(s), using rechargeable implanted pulse generator
US20050143789A1 (en) * 2001-01-30 2005-06-30 Whitehurst Todd K. Methods and systems for stimulating a peripheral nerve to treat chronic pain
US20050154419A1 (en) * 2001-01-30 2005-07-14 Whitehurst Todd K. Methods and systems for stimulating a nerve originating in an upper cervical spine area to treat a medical condition
US20050246006A1 (en) * 2004-04-30 2005-11-03 Algotec Limited Electrical nerve stimulation device
US20060004423A1 (en) * 2002-05-09 2006-01-05 Boveja Birinder R Methods and systems to provide therapy or alleviate symptoms of chronic headache, transformed migraine, and occipital neuralgia by providing rectangular and/or complex electrical pulses to occipital nerves
US20060064140A1 (en) * 2001-01-30 2006-03-23 Whitehurst Todd K Methods and systems for stimulating a trigeminal nerve to treat a psychiatric disorder
US20060079936A1 (en) * 2003-05-11 2006-04-13 Boveja Birinder R Method and system for altering regional cerebral blood flow (rCBF) by providing complex and/or rectangular electrical pulses to vagus nerve(s), to provide therapy for depression and other medical disorders
WO2006042075A3 (en) * 2004-10-07 2006-07-27 Nuvasive Inc System and methods for assessing the neuromuscular pathway prior to nerve testing
US20060206163A1 (en) * 2005-03-11 2006-09-14 Wahlstrand Carl D Neurostimulation site screening
US20060206162A1 (en) * 2005-03-11 2006-09-14 Wahlstrand Carl D Implantable neurostimulator device
US20060293723A1 (en) * 2003-12-19 2006-12-28 Whitehurst Todd K Skull-mounted electrical stimulation system and method for treating patients
US20070021801A1 (en) * 2005-06-09 2007-01-25 Medtronic, Inc. Regional therapies for treatment of pain
US20070073356A1 (en) * 2005-06-09 2007-03-29 Medtronic, Inc. Combination therapy including peripheral nerve field stimulation
US20070073357A1 (en) * 2005-06-09 2007-03-29 Medtronic, Inc. Peripheral nerve field stimulation and spinal cord stimulation
US20070118196A1 (en) * 2005-06-09 2007-05-24 Medtronic, Inc. Introducer for therapy delivery elements
US20070150034A1 (en) * 2005-06-09 2007-06-28 Medtronic, Inc. Implantable medical lead
US20080064947A1 (en) * 2006-09-08 2008-03-13 Medtronic, Inc. Method And Apparatus To Optimize Electrode Placement For Neurological Stimulation
US20080077192A1 (en) * 2002-05-03 2008-03-27 Afferent Corporation System and method for neuro-stimulation
US20080132982A1 (en) * 2006-11-30 2008-06-05 Medtronic, Inc. Method of implanting a medical device including a fixation element
US20080132980A1 (en) * 2006-11-30 2008-06-05 Medtronic, Inc. Attached implantable medical elongated members
US20090112282A1 (en) * 2007-10-26 2009-04-30 Medtronic, Inc. Occipital nerve stimulation
US20090276025A1 (en) * 2008-04-30 2009-11-05 Medtronic, Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US20100030227A1 (en) * 2008-07-31 2010-02-04 Medtronic, Inc. Medical lead implantation
DE112008003192T5 (en) 2007-11-26 2010-10-07 Micro-Transponder, Inc., Dallas Transmission coils Architecture
US20110022114A1 (en) * 2009-07-23 2011-01-27 Navarro Rosa M System and method for treating pain with peripheral and spinal neuromodulation
DE112008003193T5 (en) 2007-11-26 2011-06-30 Micro-Transponder, Inc., Tex. Arrangement connected microtransponders for implantation
US20120296389A1 (en) * 2011-05-19 2012-11-22 Neuros Medical, Inc. High-frequency electrical nerve block
US8406901B2 (en) 2006-04-27 2013-03-26 Medtronic, Inc. Sutureless implantable medical device fixation
US8588914B2 (en) 2005-06-09 2013-11-19 Medtronic, Inc. Implantable medical device with electrodes on multiple housing surfaces
WO2014031142A1 (en) 2012-08-22 2014-02-27 Medtronic, Inc. Ultrasound Diagnostic and Therapy Management System and Associated Method
US8909353B2 (en) 2003-08-29 2014-12-09 Medtronic, Inc. Percutaneous lead introducer
US9220906B2 (en) 2012-03-26 2015-12-29 Medtronic, Inc. Tethered implantable medical device deployment
US9295841B2 (en) 2011-05-19 2016-03-29 Meuros Medical, Inc. High-frequency electrical nerve block
US9339197B2 (en) 2012-03-26 2016-05-17 Medtronic, Inc. Intravascular implantable medical device introduction
US9717421B2 (en) 2012-03-26 2017-08-01 Medtronic, Inc. Implantable medical device delivery catheter with tether
US9775982B2 (en) 2010-12-29 2017-10-03 Medtronic, Inc. Implantable medical device fixation
US9833625B2 (en) 2012-03-26 2017-12-05 Medtronic, Inc. Implantable medical device delivery with inner and outer sheaths
US9854982B2 (en) 2012-03-26 2018-01-02 Medtronic, Inc. Implantable medical device deployment within a vessel

Families Citing this family (133)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6836685B1 (en) * 1998-04-07 2004-12-28 William R. Fitz Nerve stimulation method and apparatus for pain relief
US6505075B1 (en) * 1999-05-29 2003-01-07 Richard L. Weiner Peripheral nerve stimulation method
US7146217B2 (en) * 2000-07-13 2006-12-05 Northstar Neuroscience, Inc. Methods and apparatus for effectuating a change in a neural-function of a patient
US7756584B2 (en) * 2000-07-13 2010-07-13 Advanced Neuromodulation Systems, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US7010351B2 (en) * 2000-07-13 2006-03-07 Northstar Neuroscience, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US7024247B2 (en) * 2001-10-15 2006-04-04 Northstar Neuroscience, Inc. Systems and methods for reducing the likelihood of inducing collateral neural activity during neural stimulation threshold test procedures
US7299096B2 (en) * 2001-03-08 2007-11-20 Northstar Neuroscience, Inc. System and method for treating Parkinson's Disease and other movement disorders
US7831305B2 (en) * 2001-10-15 2010-11-09 Advanced Neuromodulation Systems, Inc. Neural stimulation system and method responsive to collateral neural activity
US7672730B2 (en) * 2001-03-08 2010-03-02 Advanced Neuromodulation Systems, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US7236831B2 (en) * 2000-07-13 2007-06-26 Northstar Neuroscience, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US7305268B2 (en) * 2000-07-13 2007-12-04 Northstar Neurscience, Inc. Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators
US20030125786A1 (en) * 2000-07-13 2003-07-03 Gliner Bradford Evan Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US6735475B1 (en) 2001-01-30 2004-05-11 Advanced Bionics Corporation Fully implantable miniature neurostimulator for stimulation as a therapy for headache and/or facial pain
WO2003026736A3 (en) * 2001-09-28 2003-11-06 Vertis Neuroscience Inc Methods and implantable apparatus for electrical therapy
WO2003026738A1 (en) * 2001-09-28 2003-04-03 Northstar Neuroscience, Inc. Methods and apparatus for electrically stimulating cells implanted in the nervous system
US20050075679A1 (en) * 2002-09-30 2005-04-07 Gliner Bradford E. Methods and apparatuses for treating neurological disorders by electrically stimulating cells implanted in the nervous system
US7221981B2 (en) * 2002-03-28 2007-05-22 Northstar Neuroscience, Inc. Electrode geometries for efficient neural stimulation
US10028753B2 (en) 2008-09-26 2018-07-24 Relievant Medsystems, Inc. Spine treatment kits
US20050075680A1 (en) 2003-04-18 2005-04-07 Lowry David Warren Methods and systems for intracranial neurostimulation and/or sensing
US7302298B2 (en) * 2002-11-27 2007-11-27 Northstar Neuroscience, Inc Methods and systems employing intracranial electrodes for neurostimulation and/or electroencephalography
US6959215B2 (en) * 2002-12-09 2005-10-25 Northstar Neuroscience, Inc. Methods for treating essential tremor
WO2004052449A1 (en) * 2002-12-09 2004-06-24 Northstar Neuroscience, Inc. Methods for treating neurological language disorders
US7236830B2 (en) * 2002-12-10 2007-06-26 Northstar Neuroscience, Inc. Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of Parkinson's disease and/or other movement disorders
US20040122477A1 (en) * 2002-12-19 2004-06-24 Whitehurst Todd K. Fully implantable miniature neurostimulator for spinal nerve root stimulation as a therapy for angina and peripheral vascular disease
US20040162590A1 (en) * 2002-12-19 2004-08-19 Whitehurst Todd K. Fully implantable miniature neurostimulator for intercostal nerve stimulation as a therapy for angina pectoris
JP2007500053A (en) * 2003-04-24 2007-01-11 ノーススター ニューロサイエンス インコーポレイテッド Development of visual function by stimulation of nerves, rehabilitation, and promote repair and / or restoration and performing system and method
US7684866B2 (en) * 2003-08-01 2010-03-23 Advanced Neuromodulation Systems, Inc. Apparatus and methods for applying neural stimulation to a patient
US20050102006A1 (en) * 2003-09-25 2005-05-12 Whitehurst Todd K. Skull-mounted electrical stimulation system
US7337004B2 (en) * 2004-02-09 2008-02-26 Classen Ashley M Method and apparatus for veterinary RF pain management
WO2005082453A1 (en) * 2004-02-25 2005-09-09 Advanced Neuromodulation Systems, Inc. System and method for neurological stimulation of peripheral nerves to treat low back pain
US20060030899A1 (en) * 2004-02-25 2006-02-09 O'keeffe Declan System and method for stimulating peripheral nerves to treat pain
US20060025832A1 (en) * 2004-02-25 2006-02-02 O'keeffe Declan System and method for stimulating peripheral nerves to treat pain
NL1026137C2 (en) * 2004-05-07 2005-11-08 Vanderlande Ind Nederland An apparatus for sorting products.
WO2006019764A3 (en) * 2004-07-15 2006-12-07 Northstar Neuroscience Inc Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy
US7711432B2 (en) * 2004-07-26 2010-05-04 Advanced Neuromodulation Systems, Inc. Stimulation system and method for treating a neurological disorder
WO2006014896A1 (en) * 2004-07-26 2006-02-09 Advanced Neuromodulation Systems, Inc. Stimulation system and method treating a neurological disorder
WO2006047264A1 (en) * 2004-10-21 2006-05-04 Advanced Neuromodulation Systems, Inc. Peripheral nerve stimulation to treat auditory dysfunction
CA2526327C (en) * 2004-11-09 2014-01-07 Institut National D'optique Device for transmitting multiple optically-encoded stimulation signals to multiple cell locations
US20060106430A1 (en) * 2004-11-12 2006-05-18 Brad Fowler Electrode configurations for reducing invasiveness and/or enhancing neural stimulation efficacy, and associated methods
US7565200B2 (en) 2004-11-12 2009-07-21 Advanced Neuromodulation Systems, Inc. Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects
US20070060954A1 (en) * 2005-02-25 2007-03-15 Tracy Cameron Method of using spinal cord stimulation to treat neurological disorders or conditions
US7702385B2 (en) * 2005-11-16 2010-04-20 Boston Scientific Neuromodulation Corporation Electrode contact configurations for an implantable stimulator
US20060206165A1 (en) * 2005-03-14 2006-09-14 Jaax Kristen N Occipital nerve stimulation to treat headaches and other conditions
US8423155B1 (en) 2005-03-14 2013-04-16 Boston Scientific Neuromodulation Corporation Methods and systems for facilitating stimulation of one or more stimulation sites
US7848803B1 (en) 2005-03-14 2010-12-07 Boston Scientific Neuromodulation Corporation Methods and systems for facilitating stimulation of one or more stimulation sites
US7853321B2 (en) * 2005-03-14 2010-12-14 Boston Scientific Neuromodulation Corporation Stimulation of a stimulation site within the neck or head
WO2006105098A3 (en) 2005-03-29 2007-11-22 Martin Roche Body parameter detecting sensor and method for detecting body parameters
US20110213221A1 (en) * 2005-03-29 2011-09-01 Roche Martin W Method for Detecting Body Parameters
US8929973B1 (en) 2005-10-24 2015-01-06 Lockheed Martin Corporation Apparatus and method for characterizing optical sources used with human and animal tissues
US8945197B1 (en) 2005-10-24 2015-02-03 Lockheed Martin Corporation Sight-restoring visual prosthetic and method using infrared nerve-stimulation light
US8956396B1 (en) 2005-10-24 2015-02-17 Lockheed Martin Corporation Eye-tracking visual prosthetic and method
US7736382B2 (en) 2005-09-09 2010-06-15 Lockheed Martin Corporation Apparatus for optical stimulation of nerves and other animal tissue
US20070088404A1 (en) * 2005-10-19 2007-04-19 Allen Wyler Methods and systems for improving neural functioning, including cognitive functioning and neglect disorders
US7856264B2 (en) * 2005-10-19 2010-12-21 Advanced Neuromodulation Systems, Inc. Systems and methods for patient interactive neural stimulation and/or chemical substance delivery
US7729773B2 (en) 2005-10-19 2010-06-01 Advanced Neuromodualation Systems, Inc. Neural stimulation and optical monitoring systems and methods
US8929991B2 (en) 2005-10-19 2015-01-06 Advanced Neuromodulation Systems, Inc. Methods for establishing parameters for neural stimulation, including via performance of working memory tasks, and associated kits
US8996131B1 (en) 2006-09-28 2015-03-31 Lockheed Martin Corporation Apparatus and method for managing chronic pain with infrared light sources and heat
US9011509B2 (en) 2007-11-30 2015-04-21 Lockheed Martin Corporation Individually optimized performance of optically stimulating cochlear implants
US8287337B2 (en) 2006-01-11 2012-10-16 Hcr Incorporated Cold storage doorway with airflow control system and method
US8401654B1 (en) 2006-06-30 2013-03-19 Boston Scientific Neuromodulation Corporation Methods and systems for treating one or more effects of deafferentation
US20080077200A1 (en) * 2006-09-21 2008-03-27 Aculight Corporation Apparatus and method for stimulation of nerves and automated control of surgical instruments
US20100076534A1 (en) * 2006-10-25 2010-03-25 William Alan Mock Malleable needle having a plurality of electrodes for facilitating implantation of stimulation lead and method of implanting an electrical stimulation lead
US20080103573A1 (en) * 2006-10-31 2008-05-01 Medtronic, Inc. Implantable medical elongated member including wire-like fixation elements
US7765012B2 (en) * 2006-11-30 2010-07-27 Medtronic, Inc. Implantable medical device including a conductive fixation element
US20080132933A1 (en) * 2006-11-30 2008-06-05 Medtronic, Inc. Flexible introducer
US20080132979A1 (en) * 2006-11-30 2008-06-05 Medtronic, Inc. Method of implanting a medical lead
US8012189B1 (en) 2007-01-11 2011-09-06 Lockheed Martin Corporation Method and vestibular implant using optical stimulation of nerves
US7883536B1 (en) 2007-01-19 2011-02-08 Lockheed Martin Corporation Hybrid optical-electrical probes
US9950159B2 (en) 2013-10-23 2018-04-24 Mainstay Medical Limited Systems and methods for restoring muscle function to the lumbar spine and kits for implanting the same
US9186501B2 (en) 2012-06-13 2015-11-17 Mainstay Medical Limited Systems and methods for implanting electrode leads for use with implantable neuromuscular electrical stimulator
US8068918B2 (en) * 2007-03-09 2011-11-29 Enteromedics Inc. Remote monitoring and control of implantable devices
US9072897B2 (en) 2007-03-09 2015-07-07 Mainstay Medical Limited Systems and methods for restoring muscle function to the lumbar spine
US20080249591A1 (en) * 2007-04-06 2008-10-09 Northstar Neuroscience, Inc. Controllers for implantable medical devices, and associated methods
US20080300657A1 (en) * 2007-05-31 2008-12-04 Mark Raymond Stultz Therapy system
US7630771B2 (en) * 2007-06-25 2009-12-08 Microtransponder, Inc. Grooved electrode and wireless microtransponder system
US8475506B1 (en) 2007-08-13 2013-07-02 Lockheed Martin Corporation VCSEL array stimulator apparatus and method for light stimulation of bodily tissues
US8057486B2 (en) * 2007-09-18 2011-11-15 Bioness Inc. Apparatus and method for inserting implants into the body
US8457757B2 (en) 2007-11-26 2013-06-04 Micro Transponder, Inc. Implantable transponder systems and methods
DE112008003180T5 (en) * 2007-11-26 2011-03-03 Micro-Transponder, Inc., Dallas Implantable transponder systems and procedures
US7962206B2 (en) * 2008-01-10 2011-06-14 Arkady Glukhovsky Methods for implanting electronic implants within the body
US9089707B2 (en) 2008-07-02 2015-07-28 The Board Of Regents, The University Of Texas System Systems, methods and devices for paired plasticity
US20100016732A1 (en) * 2008-07-17 2010-01-21 Lockheed Martin Corporation Apparatus and method for neural-signal capture to drive neuroprostheses or control bodily function
WO2010040142A1 (en) 2008-10-03 2010-04-08 Lockheed Martin Corporation Nerve stimulator and method using simultaneous electrical and optical signals
US8498699B2 (en) * 2008-10-03 2013-07-30 Lockheed Martin Company Method and nerve stimulator using simultaneous electrical and optical signals
US20100100011A1 (en) 2008-10-22 2010-04-22 Martin Roche System and Method for Orthopedic Alignment and Measurement
US9895530B2 (en) 2008-12-05 2018-02-20 Spr Therapeutics, Inc. Systems and methods to place one or more leads in tissue to electrically stimulate nerves of passage to treat pain
US8744570B2 (en) * 2009-01-23 2014-06-03 Lockheed Martin Corporation Optical stimulation of the brainstem and/or midbrain, including auditory areas
EP2416842B1 (en) * 2009-03-17 2017-07-05 AMS Research Corporation Electrode implantation tool
US8326426B2 (en) * 2009-04-03 2012-12-04 Enteromedics, Inc. Implantable device with heat storage
US20100324625A1 (en) * 2009-06-19 2010-12-23 Medtronic, Inc. Bracketing scar for treating pain with electrical stimulation
US8929998B2 (en) 2009-09-30 2015-01-06 Mayo Foundation For Medical Education And Research Percutaneous placement of electrodes
US9399091B2 (en) 2009-09-30 2016-07-26 Medtronic, Inc. System and method to regulate ultrafiltration
CN103079633B (en) 2010-03-11 2016-05-04 梅恩斯塔伊医疗公司 Modular stimulators for the treatment of back pain, an implantable rf ablation system and method of use
US8792978B2 (en) 2010-05-28 2014-07-29 Lockheed Martin Corporation Laser-based nerve stimulators for, E.G., hearing restoration in cochlear prostheses and method
US8788048B2 (en) 2010-11-11 2014-07-22 Spr Therapeutics, Llc Systems and methods for the treatment of pain through neural fiber stimulation
US8926542B2 (en) 2011-04-29 2015-01-06 Medtronic, Inc. Monitoring fluid volume for patients with renal disease
US8709078B1 (en) 2011-08-03 2014-04-29 Lockheed Martin Corporation Ocular implant with substantially constant retinal spacing for transmission of nerve-stimulation light
US9999763B2 (en) 2012-06-13 2018-06-19 Mainstay Medical Limited Apparatus and methods for anchoring electrode leads adjacent to nervous tissue
WO2014057361A3 (en) 2012-07-26 2014-07-24 Adi Mashiach Implant holder and suture guide
US10052097B2 (en) 2012-07-26 2018-08-21 Nyxoah SA Implant unit delivery tool
US9351648B2 (en) 2012-08-24 2016-05-31 Medtronic, Inc. Implantable medical device electrode assembly
EP2891239A1 (en) 2012-08-31 2015-07-08 The Alfred E. Mann Foundation for Scientific Research Feedback controlled coil driver for inductive power transfer
CA2889478A1 (en) 2012-11-05 2014-05-08 Relievant Medsystems, Inc. Systems and methods for creating curved paths through bone and modulating nerves within the bone
US9409009B2 (en) 2012-11-07 2016-08-09 The Florida International University Multi-lead multi-electrode management system
RU2504412C1 (en) * 2012-11-28 2014-01-20 Федеральное государственное бюджетное учреждение "Российский научный центр "Восстановительная травматология и ортопедия" имени академика Г.А. Илизарова" Министерства здравоохранения Российской Федерации Method of treating sciatic neuropathy following hip replacement or acetabular facture
WO2014099423A1 (en) * 2012-12-06 2014-06-26 Spr Therapeutics, Llc Systems and methods to place one or more leads in tissue to electrically stimulate nerves of passage to treat pain
US8880173B2 (en) 2013-03-12 2014-11-04 Ethicon Endo-Surgery, Inc. Device for providing transdermal electrical stimulation at an adjustable position on a head
WO2014146019A3 (en) 2013-03-15 2015-03-05 Alfred E. Mann Foundation For Scientific Research High voltage monitoring successive approximation analog to digital converter
US20160030408A1 (en) * 2013-03-15 2016-02-04 Bhl Patent Holdings Llc Materials and methods for treating neuropathies and related disorders including those involving a keystone nerve
US9446241B2 (en) 2013-03-15 2016-09-20 Alfred E. Mann Foundation For Scientific Research Current sensing multiple output current stimulators
EP2991728A1 (en) 2013-05-03 2016-03-09 Alfred E. Mann Foundation for Scientific Research Implant recharger handshaking system and method
CA2910943A1 (en) 2013-05-03 2014-11-06 Alfred E. Mann Foundation For Scientific Research High reliability wire welding for implantable devices
CA2910982A1 (en) 2013-05-03 2014-11-06 Alfred E. Mann Foundation For Scientific Research Multi-branch stimulation electrode for subcutaneous field stimulation
US20150028805A1 (en) 2013-07-29 2015-01-29 Alfred E. Mann Foundation For Scientific Research Implant charging field control through radio link
WO2015017475A3 (en) 2013-07-29 2015-04-02 Alfred E. Mann Foundation For Scientific Research Microprocessor controlled class e driver
CN105263572B (en) 2013-07-29 2017-10-17 艾尔弗雷德·E·曼科学研究基金会 A high efficiency of the magnetic link implantable device
US9724151B2 (en) 2013-08-08 2017-08-08 Relievant Medsystems, Inc. Modulating nerves within bone using bone fasteners
US9042991B2 (en) 2013-08-14 2015-05-26 Syntilla Medical LLC Implantable head mounted neurostimulation system for head pain
US9427566B2 (en) 2013-08-14 2016-08-30 Syntilla Medical LLC Implantable neurostimulation lead for head pain
US9839777B2 (en) 2013-08-14 2017-12-12 Syntilla Medical LLC Implantable neurostimulation lead for head pain
US9884190B2 (en) 2013-10-23 2018-02-06 Syntilla Medical LLC Surgical method for implantable head mounted neurostimulation system for head pain
US9498635B2 (en) 2013-10-16 2016-11-22 Syntilla Medical LLC Implantable head located radiofrequency coupled neurostimulation system for head pain
JP2017523867A (en) 2014-08-15 2017-08-24 アクソニクス モジュレーション テクノロジーズ インコーポレイテッド External pulse generator device and an associated method for testing nerve stimulation
JP2017523870A (en) 2014-08-15 2017-08-24 アクソニクス モジュレーション テクノロジーズ インコーポレイテッド Implantable lead affixed structure for neural stimulation to relieve bladder dysfunction and other symptoms
JP2017523869A (en) 2014-08-15 2017-08-24 アクソニクス モジュレーション テクノロジーズ インコーポレイテッド Systems and methods for neural stimulation electrode configurations based on nerve localization
WO2016025913A1 (en) 2014-08-15 2016-02-18 Axonics Modulation Technologies, Inc. Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder
US9643003B2 (en) 2014-11-10 2017-05-09 Steven Sounyoung Yu Craniofacial neurostimulation for treatment of pain conditions
US20170361089A1 (en) * 2014-12-10 2017-12-21 Spr Therapeutics, Llc Apparatus and method for treating headaches
EP3242712A4 (en) 2015-01-09 2018-07-25 Axonics Modulation Tech Inc Patient remote and associated methods of use with a nerve stimulation system
CA2973192A1 (en) 2015-01-09 2016-07-14 Axonics Modulation Technologies, Inc. Improved antenna and methods of use for an implantable nerve stimulator
US20170007836A1 (en) 2015-07-10 2017-01-12 Axonics Modulation Technologies, Inc. Implantable nerve stimulator having internal electronics without asic and methods of use
US9717917B2 (en) 2016-01-06 2017-08-01 Syntilla Medical LLC Charging system incorporating independent charging and communication with multiple implanted devices
US9517338B1 (en) 2016-01-19 2016-12-13 Axonics Modulation Technologies, Inc. Multichannel clip device and methods of use

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957036A (en) * 1975-02-03 1976-05-18 Baylor College Of Medicine Method and apparatus for recording activity in intact nerves
US4157087A (en) * 1978-03-06 1979-06-05 Med General, Inc. Peripheral nerve stimulator
US4233986A (en) * 1978-07-18 1980-11-18 Agar Ginosar Electronics And Metal Products Apparatus and method for controlling pain by transcutaneous electrical stimulation (TES)
US4379462A (en) * 1980-10-29 1983-04-12 Neuromed, Inc. Multi-electrode catheter assembly for spinal cord stimulation
US4612934A (en) * 1981-06-30 1986-09-23 Borkan William N Non-invasive multiprogrammable tissue stimulator
US4512351A (en) * 1982-11-19 1985-04-23 Cordis Corporation Percutaneous lead introducing system and method
US4542753A (en) * 1982-12-22 1985-09-24 Biosonics, Inc. Apparatus and method for stimulating penile erectile tissue
US4586509A (en) * 1984-01-09 1986-05-06 Pain Suppression Labs, Inc. Temporomandibular joint-myofascial pain dysfunction syndrome treatment apparatus and methodology
US4590946A (en) * 1984-06-14 1986-05-27 Biomed Concepts, Inc. Surgically implantable electrode for nerve bundles
US5374261A (en) * 1990-07-24 1994-12-20 Yoon; Inbae Multifunctional devices for use in endoscopic surgical procedures and methods-therefor
WO1993023113A1 (en) * 1992-05-18 1993-11-25 Edison Biotechnology Center Subcutaneous electrode for stimulating skeletal musculature
US5792187A (en) * 1993-02-22 1998-08-11 Angeion Corporation Neuro-stimulation to control pain during cardioversion defibrillation
US5505201A (en) * 1994-04-20 1996-04-09 Case Western Reserve University Implantable helical spiral cuff electrode
EP0873105B1 (en) * 1995-12-22 2006-05-10 Roberto Deli Device to modify the excitability of the neural networks
US5904711A (en) * 1996-02-08 1999-05-18 Heartport, Inc. Expandable thoracoscopic defibrillation catheter system and method
US5938690A (en) * 1996-06-07 1999-08-17 Advanced Neuromodulation Systems, Inc. Pain management system and method
US5983141A (en) 1996-06-27 1999-11-09 Radionics, Inc. Method and apparatus for altering neural tissue function
US6104957A (en) * 1998-08-21 2000-08-15 Alo; Kenneth M. Epidural nerve root stimulation with lead placement method
US6309401B1 (en) * 1999-04-30 2001-10-30 Vladimir Redko Apparatus and method for percutaneous implant of a paddle style lead
US6505075B1 (en) * 1999-05-29 2003-01-07 Richard L. Weiner Peripheral nerve stimulation method
WO2000076578A1 (en) * 1999-06-14 2000-12-21 Marcus Norman J Method for direct diagnosis and treatment of pain of muscular origin
US7610104B2 (en) * 2002-05-10 2009-10-27 Cerebral Vascular Applications, Inc. Methods and apparatus for lead placement on a surface of the heart

Cited By (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060064140A1 (en) * 2001-01-30 2006-03-23 Whitehurst Todd K Methods and systems for stimulating a trigeminal nerve to treat a psychiatric disorder
US20050143789A1 (en) * 2001-01-30 2005-06-30 Whitehurst Todd K. Methods and systems for stimulating a peripheral nerve to treat chronic pain
US20050154419A1 (en) * 2001-01-30 2005-07-14 Whitehurst Todd K. Methods and systems for stimulating a nerve originating in an upper cervical spine area to treat a medical condition
US7493172B2 (en) 2001-01-30 2009-02-17 Boston Scientific Neuromodulation Corp. Methods and systems for stimulating a nerve originating in an upper cervical spine area to treat a medical condition
US9616234B2 (en) 2002-05-03 2017-04-11 Trustees Of Boston University System and method for neuro-stimulation
US20080077192A1 (en) * 2002-05-03 2008-03-27 Afferent Corporation System and method for neuro-stimulation
US20060004423A1 (en) * 2002-05-09 2006-01-05 Boveja Birinder R Methods and systems to provide therapy or alleviate symptoms of chronic headache, transformed migraine, and occipital neuralgia by providing rectangular and/or complex electrical pulses to occipital nerves
US20050143787A1 (en) * 2002-05-09 2005-06-30 Boveja Birinder R. Method and system for providing electrical pulses for neuromodulation of vagus nerve(s), using rechargeable implanted pulse generator
US20060079936A1 (en) * 2003-05-11 2006-04-13 Boveja Birinder R Method and system for altering regional cerebral blood flow (rCBF) by providing complex and/or rectangular electrical pulses to vagus nerve(s), to provide therapy for depression and other medical disorders
US9687637B2 (en) 2003-08-29 2017-06-27 Medtronic, Inc. Percutaneous flat lead introducer
US8909353B2 (en) 2003-08-29 2014-12-09 Medtronic, Inc. Percutaneous lead introducer
US20050060008A1 (en) * 2003-09-15 2005-03-17 Goetz Steven M. Selection of neurostimulator parameter configurations using bayesian networks
WO2005028022A1 (en) * 2003-09-15 2005-03-31 Medtronic, Inc. Selection of neurostimulator parameter configurations using bayesian networks
US7184837B2 (en) 2003-09-15 2007-02-27 Medtronic, Inc. Selection of neurostimulator parameter configurations using bayesian networks
US7769461B2 (en) 2003-12-19 2010-08-03 Boston Scientific Neuromodulation Corporation Skull-mounted electrical stimulation system and method for treating patients
US20060293723A1 (en) * 2003-12-19 2006-12-28 Whitehurst Todd K Skull-mounted electrical stimulation system and method for treating patients
US20110009920A1 (en) * 2003-12-19 2011-01-13 Boston Scientific Neuromodulation Corporation Skull-mounted electrical stimulation system and method for treating patients
US20050246006A1 (en) * 2004-04-30 2005-11-03 Algotec Limited Electrical nerve stimulation device
US8538539B2 (en) 2004-10-07 2013-09-17 Nu Vasive, Inc. System and methods for assessing the neuromuscular pathway prior to nerve testing
US8989866B2 (en) 2004-10-07 2015-03-24 Nuvasive, Inc. System and methods for assessing the neuromuscular pathway prior to nerve testing
WO2006042075A3 (en) * 2004-10-07 2006-07-27 Nuvasive Inc System and methods for assessing the neuromuscular pathway prior to nerve testing
US7664552B2 (en) 2005-03-11 2010-02-16 Medtronic, Inc. Neurostimulation site screening
US20070208391A1 (en) * 2005-03-11 2007-09-06 Medtronic, Inc. Neurostimulation site screening
US20070162087A1 (en) * 2005-03-11 2007-07-12 Medtronic, Inc. Neurostimulation site screening
US7231256B2 (en) 2005-03-11 2007-06-12 Medtronic, Inc. Neurostimulation site screening
US8744582B2 (en) 2005-03-11 2014-06-03 Medtronic, Inc. Implantable neurostimulator device with bellows-like element coupling first and second housing portions
US20060206162A1 (en) * 2005-03-11 2006-09-14 Wahlstrand Carl D Implantable neurostimulator device
US8295936B2 (en) 2005-03-11 2012-10-23 Medtronic, Inc. Implantable neurostimulator device
US8620437B2 (en) 2005-03-11 2013-12-31 Medtronic, Inc. Method for delivery of electrical stimulation with bendable housing
US7555345B2 (en) 2005-03-11 2009-06-30 Medtronic, Inc. Implantable neurostimulator device
US20090234420A1 (en) * 2005-03-11 2009-09-17 Medtronic, Inc. Implantable neurostimulator device
US20090240303A1 (en) * 2005-03-11 2009-09-24 Medtronic. Inc. Method for delivery of electrical stimulation
US20060206163A1 (en) * 2005-03-11 2006-09-14 Wahlstrand Carl D Neurostimulation site screening
US7676271B2 (en) 2005-03-11 2010-03-09 Medtronic, Inc. Neurostimulation site screening
US20100049277A1 (en) * 2005-03-11 2010-02-25 Medtronic, Inc. Implantable neurostimulator device
US9149628B2 (en) 2005-03-11 2015-10-06 Medtronic, Inc. Neurostimulator for treating occipital neuralgia with housing sized and curved to conform to a subcutaneous neck region
US9020599B2 (en) 2005-06-09 2015-04-28 Medtronic, Inc. Combination therapy including peripheral nerve field stimulation
US9084872B2 (en) 2005-06-09 2015-07-21 Medtronic, Inc. Introducer for therapy delivery elements
US20070150034A1 (en) * 2005-06-09 2007-06-28 Medtronic, Inc. Implantable medical lead
US9320847B2 (en) 2005-06-09 2016-04-26 Medtronic, Inc. Combination therapy including peripheral nerve field stimulation
US7792591B2 (en) 2005-06-09 2010-09-07 Medtronic, Inc. Introducer for therapy delivery elements
US20070118196A1 (en) * 2005-06-09 2007-05-24 Medtronic, Inc. Introducer for therapy delivery elements
US7813803B2 (en) 2005-06-09 2010-10-12 Medtronic, Inc. Regional therapies for treatment of pain
US20070073357A1 (en) * 2005-06-09 2007-03-29 Medtronic, Inc. Peripheral nerve field stimulation and spinal cord stimulation
US20070073356A1 (en) * 2005-06-09 2007-03-29 Medtronic, Inc. Combination therapy including peripheral nerve field stimulation
US7890166B2 (en) 2005-06-09 2011-02-15 Medtronic, Inc. Regional therapies for treatment of pain
US8644941B2 (en) * 2005-06-09 2014-02-04 Medtronic, Inc. Peripheral nerve field stimulation and spinal cord stimulation
US8204607B2 (en) 2005-06-09 2012-06-19 Medtronic, Inc. Implantable medical lead
US8244360B2 (en) 2005-06-09 2012-08-14 Medtronic, Inc. Regional therapies for treatment of pain
US20070039625A1 (en) * 2005-06-09 2007-02-22 Medtronic, Inc. Regional therapies for treatment of pain
US20070021801A1 (en) * 2005-06-09 2007-01-25 Medtronic, Inc. Regional therapies for treatment of pain
US8620435B2 (en) * 2005-06-09 2013-12-31 Medtronic, Inc. Combination therapy including peripheral nerve field stimulation
US8588914B2 (en) 2005-06-09 2013-11-19 Medtronic, Inc. Implantable medical device with electrodes on multiple housing surfaces
US9393416B2 (en) 2005-06-09 2016-07-19 Medtronic, Inc. Peripheral nerve field stimulation and spinal cord stimulation
US8406901B2 (en) 2006-04-27 2013-03-26 Medtronic, Inc. Sutureless implantable medical device fixation
US20140012131A1 (en) * 2006-09-08 2014-01-09 Medtronic, Inc. Method And Apparatus To Optimize Electrode Placement For Neurological Stimulation
US20080064947A1 (en) * 2006-09-08 2008-03-13 Medtronic, Inc. Method And Apparatus To Optimize Electrode Placement For Neurological Stimulation
US8532741B2 (en) 2006-09-08 2013-09-10 Medtronic, Inc. Method and apparatus to optimize electrode placement for neurological stimulation
US20080132982A1 (en) * 2006-11-30 2008-06-05 Medtronic, Inc. Method of implanting a medical device including a fixation element
US9492657B2 (en) * 2006-11-30 2016-11-15 Medtronic, Inc. Method of implanting a medical device including a fixation element
US7774072B2 (en) * 2006-11-30 2010-08-10 Medtronic, Inc. Attached implantable medical elongated members
US20080132980A1 (en) * 2006-11-30 2008-06-05 Medtronic, Inc. Attached implantable medical elongated members
US9008782B2 (en) 2007-10-26 2015-04-14 Medtronic, Inc. Occipital nerve stimulation
US20090112282A1 (en) * 2007-10-26 2009-04-30 Medtronic, Inc. Occipital nerve stimulation
US9427572B2 (en) 2007-10-26 2016-08-30 Medtronic, Inc. Implantable medical device with connector blocks
DE112008003193T5 (en) 2007-11-26 2011-06-30 Micro-Transponder, Inc., Tex. Arrangement connected microtransponders for implantation
DE112008003192T5 (en) 2007-11-26 2010-10-07 Micro-Transponder, Inc., Dallas Transmission coils Architecture
US9561369B2 (en) 2008-04-30 2017-02-07 Medtronic, Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US8315713B2 (en) 2008-04-30 2012-11-20 Medtronic, Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US9572982B2 (en) 2008-04-30 2017-02-21 Medtronic, Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US20090276022A1 (en) * 2008-04-30 2009-11-05 Medtronic , Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US20090276025A1 (en) * 2008-04-30 2009-11-05 Medtronic, Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US8532793B2 (en) 2008-04-30 2013-09-10 Medtronic, Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US20100030227A1 (en) * 2008-07-31 2010-02-04 Medtronic, Inc. Medical lead implantation
US8452417B2 (en) 2009-07-23 2013-05-28 Rosa M. Navarro System and method for treating pain with peripheral and spinal neuromodulation
US20110022114A1 (en) * 2009-07-23 2011-01-27 Navarro Rosa M System and method for treating pain with peripheral and spinal neuromodulation
US9844659B2 (en) 2010-12-29 2017-12-19 Medtronic, Inc. Implantable medical device fixation
US9775982B2 (en) 2010-12-29 2017-10-03 Medtronic, Inc. Implantable medical device fixation
US8983612B2 (en) 2011-05-19 2015-03-17 Neuros Medical, Inc. High-frequency electrical nerve block
US8731676B2 (en) * 2011-05-19 2014-05-20 Neuros Medical, Inc. High-frequency electrical nerve block
US9295841B2 (en) 2011-05-19 2016-03-29 Meuros Medical, Inc. High-frequency electrical nerve block
US20120296389A1 (en) * 2011-05-19 2012-11-22 Neuros Medical, Inc. High-frequency electrical nerve block
US9717421B2 (en) 2012-03-26 2017-08-01 Medtronic, Inc. Implantable medical device delivery catheter with tether
US9854982B2 (en) 2012-03-26 2018-01-02 Medtronic, Inc. Implantable medical device deployment within a vessel
US9833625B2 (en) 2012-03-26 2017-12-05 Medtronic, Inc. Implantable medical device delivery with inner and outer sheaths
US9339197B2 (en) 2012-03-26 2016-05-17 Medtronic, Inc. Intravascular implantable medical device introduction
US9220906B2 (en) 2012-03-26 2015-12-29 Medtronic, Inc. Tethered implantable medical device deployment
WO2014031142A1 (en) 2012-08-22 2014-02-27 Medtronic, Inc. Ultrasound Diagnostic and Therapy Management System and Associated Method

Also Published As

Publication number Publication date Type
US20060206166A1 (en) 2006-09-14 application
US8774924B2 (en) 2014-07-08 grant
US20120041512A1 (en) 2012-02-16 application
US9333339B2 (en) 2016-05-10 grant
US6505075B1 (en) 2003-01-07 grant

Similar Documents

Publication Publication Date Title
US7236831B2 (en) Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US6104957A (en) Epidural nerve root stimulation with lead placement method
US7555345B2 (en) Implantable neurostimulator device
Nashold Jr et al. Dorsal column stimulation for control of pain: Preliminary report on 30 patients
Rushton Electrical stimulation in the treatment of pain
US7174215B2 (en) Method for determining stimulation parameters
US6533732B1 (en) Nerve stimulator needle guidance system
US6233488B1 (en) Spinal cord stimulation as a treatment for addiction to nicotine and other chemical substances
US5776170A (en) Electrotherapeutic apparatus
Thon et al. Neuromodulation of voiding dysfunction and pelvic pain
US6609025B2 (en) Treatment of obesity by bilateral sub-diaphragmatic nerve stimulation
Mushahwar et al. Spinal cord microstimulation generates functional limb movements in chronically implanted cats
US6314325B1 (en) Nerve hyperpolarization method and apparatus for pain relief
Bertrand Selective peripheral denervation for spasmodic torticollis: surgical technique, results, and observations in 260 cases
US7263402B2 (en) System and method of rapid, comfortable parameter switching in spinal cord stimulation
Ebel et al. Chronic precentral stimulation in trigeminal neuropathic pain
Paicius et al. Peripheral nerve field stimulation in chronic abdominal pain
US6308103B1 (en) Self-centering epidural spinal cord lead and method
US6847849B2 (en) Minimally invasive apparatus for implanting a sacral stimulation lead
US4141365A (en) Epidural lead electrode and insertion needle
US20060206163A1 (en) Neurostimulation site screening
US6167311A (en) Method of treating psychological disorders by brain stimulation within the thalamus
US5423877A (en) Method and device for acute pain management by simultaneous spinal cord electrical stimulation and drug infusion
US6567702B1 (en) Eliciting analgesia by transcranial electrical stimulation
US20070265675A1 (en) Testing Efficacy of Therapeutic Mechanical or Electrical Nerve or Muscle Stimulation